Cargando…

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome

Understanding the cardiovascular disease (CVD) risk for women with polycystic ovary syndrome (PCOS) at reproductive age is crucial. To investigate this, we compared the cardiometabolic profiles of different PCOS groups over a median interval of 15.8 years. The study focused on three groups: (1) wome...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Ham, Kim, Koster, Maria P. H., Velthuis, Birgitta K., Budde, Ricardo P. J., Fauser, Bart C. J. M., Laven, Joop S. E., Louwers, Yvonne V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455407/ https://www.ncbi.nlm.nih.gov/pubmed/37629271 http://dx.doi.org/10.3390/jcm12165226

Ejemplares similares

Characteristics of polycystic ovary syndrome throughout life
por: Louwers, Yvonne V., et al.
Publicado: (2020)

Trabecular bone density in middle-aged women with reproductive disorders
por: van Zwol-Janssens, Charissa, et al.
Publicado: (2023)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Incidental findings on coronary computed tomography in women with selected reproductive disorders
por: van der Ham, Kim, et al.
Publicado: (2022)

Bone morphogenetic proteins and the polycystic ovary syndrome
por: van Houten, E Leonie AF, et al.
Publicado: (2013)

Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022)

Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity?
por: Huijgen, Nicole A., et al.
Publicado: (2015)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
por: Fraser, Graeme L, et al.
Publicado: (2021)

BMI-Associated Alleles Do Not Constitute Risk Alleles for Polycystic Ovary Syndrome Independently of BMI: A Case-Control Study
por: Louwers, Yvonne V., et al.
Publicado: (2014)

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS
por: Jiskoot, Geranne, et al.
Publicado: (2023)

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
por: Krul-Poel, Y. H. M., et al.
Publicado: (2018)

Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout
por: Jiskoot, Geranne, et al.
Publicado: (2022)

Androgen Receptor Blocker Improves the Cardiometabolic Profile in a Rat Model of Polycystic Ovary Syndrome, but at What Cost?
por: Pruett, Jacob E, et al.
Publicado: (2021)

PMON206 Pregnancy Rate and Outcomes Following a Randomized Controlled Three-component Lifestyle Intervention in Women with PCOS
por: van der Ham, Kim, et al.
Publicado: (2022)

Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome(†)(‡)
por: Teede, Helena J, et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence
por: Steegers-Theunissen, Régine P. M., et al.
Publicado: (2020)

Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study
por: Pastoor, Hester, et al.
Publicado: (2020)

Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J, et al.
Publicado: (2019)

Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome
por: Day, Felix R., et al.
Publicado: (2015)

Androgen receptor splice variants and polycystic ovary syndrome: cause or effect?
por: Walters, Kirsty A, et al.
Publicado: (2016)

The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies
por: Hiam, Danielle, et al.
Publicado: (2019)

The interplay between androgens and the immune response in polycystic ovary syndrome
por: Shabbir, Sania, et al.
Publicado: (2023)

Changes in eating behavior through lifestyle treatment in women with polycystic ovary syndrome (PCOS): a randomized controlled trial
por: Jiskoot, Geranne, et al.
Publicado: (2022)

The prevalence of thyroid dysfunction and hyperprolactinemia in women with PCOS
por: van der Ham, Kim, et al.
Publicado: (2023)

Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats
por: Wang, Fang, et al.
Publicado: (2012)

MON-208 Association Study of AMH Promoter Polymorphisms and Serum AMH Levels in PCOS Patients
por: Moolhuijsen, Loes, et al.
Publicado: (2019)

Pregnancy Outcomes in Women with PCOS: Follow-Up Study of a Randomized Controlled Three-Component Lifestyle Intervention
por: Dietz de Loos, Alexandra, et al.
Publicado: (2023)

Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018)

Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020)

High androgen concentrations in follicular fluid of polycystic ovary syndrome women
por: Bongrani, Alice, et al.
Publicado: (2022)

Androgen-Induced Cardiovascular Risk in Polycystic Ovary Syndrome: The Role of T Lymphocytes
por: Moulana, Mohadetheh
Publicado: (2023)

THU629 Cluster Analysis Identifies Distinct Subtypes Of PCOS
por: van der Ham, Kim, et al.
Publicado: (2023)

The Relationship between Vitamin D Metabolites and Androgens in Women with Polycystic Ovary Syndrome
por: Mesinovic, Jakub, et al.
Publicado: (2020)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tfgh3puekokittufmjfjq1kl0s